As Ocuphire Pharma Rally Gathers Steam Post-Results, What Did Investors Initially Miss?

Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (US:OCUP) announced its fourth-quarter and year-end financial results on March 30, indicating a successful year with significant clinical, regulatory, patent, and strategic partner milestones. OCUP shares climbed a little…#ocuphirepharmainc #ocuphire #nyxol #famy #bigbeat #roic #ttm #minasooch #apx3330 #ocuphirepharmas
Source: Reuters: Health - Category: Consumer Health News Source Type: news